nimesulide (Compound)

Synonyms:nimesulide, 51803-78-2, N-(4-Nitro-2-phenoxyphenyl)methanesulfonamide, Mesulid, Aulin, Flogovital, Sulidene, Nimed, 4-NITRO-2-PHENOXYMETHANESULFONANILIDE, R-805, Methanesulfonamide, N-(4-nitro-2-phenoxyphenyl)-, R 805, Nisulid, 4'-Nitro-2'-phenoxymethanesulfonanilide, 4-Nitro-2-phenoxy-methanesulfonanilide, NSC-758412, CHEMBL56367, MLS000069680, V4TKW1454M, Methanesulfonanilide, 4'-nitro-2'-phenoxy-, DTXSID3037250, CHEBI:44445, NCGC00015725-02, R805, SMR000058484, CAS-51803-78-2, DTXCID1017250, Antifloxil, Nimesulida, Nimesulidum, Guaxan, Nimesulidum [INN-Latin], Nimesulida [INN-Spanish], NIM, Nimesulide [INN:BAN], SR-01000000218, EINECS 257-431-4, 4'-Nitro-2'-phenoxymethansulfonanilid, BRN 2421175, UNII-V4TKW1454M, Aldoron, Nimedex, Orthobid, CCRIS 8225, Nise Gel, Nimesulide,(S), Prestwick_618, MFCD00079470, Spectrum_001577, NIMESULIDE [MI], Nimesulide (JAN/INN), NIMESULIDE [INN], NIMESULIDE [JAN], Opera_ID_1247, Prestwick0_000194, Prestwick1_000194, Prestwick2_000194, Prestwick3_000194, Spectrum2_001541, Spectrum3_001576, Spectrum4_000178, Spectrum5_000964, Lopac-N-1016, N-(4-nitro-2-phenoxy-phenyl)methanesulfonamide, NIMESULIDE [MART.], NIMESULIDE [WHO-DD], Lopac0_000855, SCHEMBL24882, BSPBio_000147, BSPBio_001103, BSPBio_003112, KBioGR_000443, KBioGR_000695, KBioSS_000443, KBioSS_002057, MLS001148268, DivK1c_000693, SPECTRUM1503231, SPBio_001382, SPBio_002068, N-(4-nitro-2-phenoxyphenyl), BPBio1_000163, GTPL7401, NIM-03, NIMESULIDE [EP IMPURITY], BCBcMAP01_000034, HMS502C15, KBio1_000693, KBio2_000443, KBio2_002057, KBio2_003011, KBio2_004625, KBio2_005579, KBio2_007193, KBio3_000825, KBio3_000826, KBio3_002612, NIMESULIDE [EP MONOGRAPH], Nimesulide for peak identification, NINDS_000693, Bio2_000382, Bio2_000862, HMS1362G05, HMS1568H09, HMS1792G05, HMS1922K17, HMS1990G05, HMS2089B14, HMS2095H09, HMS2234K19, HMS3262L11, HMS3269G17, HMS3371J19, HMS3403G05, HMS3414P09, HMS3649A04, HMS3655D13, HMS3678P07, HMS3712H09, HMS3884C22, Pharmakon1600-01503231, BCP10076, HY-B0363, Tox21_110207, Tox21_301850, Tox21_500855, BDBM50056999, CCG-39319, EI-287, NSC758412, s2040, STL018679, AKOS015897356, Tox21_110207_1, AC-4524, DB04743, KS-1277, LP00855, NSC 758412, SDCCGSBI-0050831.P004, IDI1_000693, IDI1_002137, NCGC00015725-01, NCGC00015725-03, NCGC00015725-04, NCGC00015725-05, NCGC00015725-06, NCGC00015725-07, NCGC00015725-08, NCGC00015725-09, NCGC00015725-10, NCGC00015725-11, NCGC00015725-12, NCGC00015725-13, NCGC00015725-15, NCGC00015725-16, NCGC00015725-29, NCGC00021842-03, NCGC00021842-04, NCGC00021842-05, NCGC00021842-06, NCGC00021842-07, NCGC00021842-08, NCGC00255661-01, NCGC00261540-01, BN166246, Nimesulide 100 microg/mL in Acetonitrile, SBI-0050831.P003, DB-052029, AB00052332, EU-0100855, FT-0630650, N0984, SW196785-3, D01049, D70376, N 1016, Q20994, AB00052332-16, AB00052332_17, AB00052332_18, EN300-7388636, N-[4-nitro-2-(phenoxy)phenyl]methanesulfonamide, A828786, SR-01000000218-2, SR-01000000218-6, SR-01000000218-7, W-105866, BRD-K76775527-001-06-2, BRD-K76775527-001-18-7, SR-01000000218-11, Nimesulide, European Pharmacopoeia (EP) Reference Standard, Nimesulide, Pharmaceutical Secondary Standard; Certified Reference Material, Nimesulide for peak identification, European Pharmacopoeia (EP) Reference Standard, 1364966-82-4
Pubchem:PUBCHEM:4495
Id:d3f700fb-ff6c-5d8e-bf9e-07d22e1d6d76
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View nimesulide's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for nimesulide.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with nimesulide.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.